News of Note—Altimmune’s new CEO, Scripps’ HIV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Altimmune has poached Neos Therapeutics’ CEO, Vipin Crag, Ph.D., to succeed Bill Enright as its president and CEO. Release

> Scripps Research scientists have found a way to stabilize HIV envelope protein for a new HIV vaccine. The candidate elicited robust anti-HIV antibody responses in mice and rabbits, the team reported. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> The NIH awarded Tulane University School of Medicine a contract worth up to $8.5 million to develop a more effective and longer-lasting vaccine against whooping cough. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.